- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07289633
Evaluation of Postoperative Pain After Using Resin-Based and Bioceramic Sealers in Mandibular Molars With Asymptomatic Apical Periodontitis
Evaluation of the Effect of Resin-Based and Bioceramic Sealers on Postoperative Pain in Mandibular Molars With Asymptomatic Apical Periodontitis Treated in a Single Visit
The goal of this clinical trial is to compare two root canal sealers in adults who need root canal treatment of a lower back tooth (mandibular first or second molar) with a dead (necrotic) pulp and no pain before treatment. The main question it aims to answer is: Does the type of sealer used to fill the root canals affect pain after single-visit root canal treatment?
Researchers compared a calcium silicate-based sealer (BioRoot RCS) with an epoxy resin-based sealer (AH Plus).
Participants:
Received root canal treatment completed in a single visit, with canals filled using the cold lateral compaction technique and one of the two sealers, assigned at random Recorded their pain on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7 after treatment Recorded whether, when, and how much pain medication (ibuprofen) they took during the 7-day follow-up
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This single-center, parallel-group randomized controlled trial was conducted at the Department of Endodontics, Faculty of Dentistry, Atatürk University (Erzurum, Türkiye). Seventy patients with a mandibular first or second molar with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (periapical index score ≤ 3), without preoperative pain, were randomly allocated in a 1:1 ratio to the BioRoot RCS group or the AH Plus group (35 per group).
All treatments were performed in a single visit by one operator following a standardized protocol. Canals were shaped with the WaveOne Gold reciprocating system and irrigated with 2.5% sodium hypochlorite, followed by final irrigation with 17% EDTA, 2.5% sodium hypochlorite, and saline. Allocation was concealed in sequentially numbered, opaque, sealed envelopes opened immediately before obturation. In both groups, canals were obturated by cold lateral compaction, and the teeth were permanently restored in the same visit.
The primary outcome was postoperative pain intensity on a 100 mm visual analog scale at 6, 12, and 24 hours and on days 2, 3, 5, and 7. The secondary outcome was the proportion of participants who used rescue analgesics (ibuprofen 400 mg) during the 7-day follow-up.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
palandöken
-
Erzurum, palandöken, Turkey (Türkiye), 25100
- Atatürk University Faculty of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18-65 years
- American Society of Anesthesiologists (ASA) physical status I
- Mandibular first or second molar with complete root formation and no previous endodontic treatment
- Pulp necrosis (no response to cold and electric pulp tests), confirmed clinically by the absence of bleeding in the pulp chamber during access cavity preparation
- Normal apical tissues or asymptomatic apical periodontitis according to the American Association of Endodontists diagnostic terminology (periapical index score of 3 or less)
- No spontaneous pain and no tenderness to percussion or palpation before treatment
- No analgesic intake within the previous 72 hours and no antibiotic intake within the previous month
- Written informed consent
Exclusion Criteria:
- Systemic disease, immunodeficiency, or regular medication use
- Pregnancy
- Known allergy to the materials or drugs used in the study
- Symptomatic apical periodontitis, acute apical abscess, or chronic apical abscess
- Swelling or sinus tract
- Periodontal probing depth greater than 3 mm
- Root canal calcification, internal or external root resorption, or open apex
- Teeth requiring a post-and-core restoration
- Periapical index score greater than 3
- Bleeding in the pulp chamber during access cavity preparation (pulp necrosis not confirmed)
- Two canals in the distal root
- Treatment that could not be completed in a single visit or that required intracanal medication
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BioRoot RCS Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the calcium silicate-based sealer BioRoot RCS. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the calcium silicate-based sealer BioRoot RCS (Septodont). No intracanal medication was used. |
|
Active Comparator: AH Plus Group
Single-visit root canal treatment of mandibular molars with pulp necrosis; canals obturated by cold lateral compaction using the epoxy resin-based sealer AH Plus. |
Single-visit root canal treatment of mandibular first or second molars with pulp necrosis and either normal apical tissues or asymptomatic apical periodontitis (PAI ≤ 3). Canals were shaped with the WaveOne Gold reciprocating system, irrigated with 2.5% NaOCl, and finally irrigated with 17% EDTA, 2.5% NaOCl, and saline. Canals were obturated by cold lateral compaction using gutta-percha cones and the epoxy resin-based sealer AH Plus (Dentsply DeTrey). No intracanal medication was used. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain intensity
Time Frame: 6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Postoperative pain intensity was self-recorded by participants on a 100 mm visual analog scale (VAS), where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain. VAS scores were categorized as no pain (0-4 mm), mild (5-34 mm), moderate (35-64 mm), severe (65-85 mm), and very severe pain (86-100 mm), and the groups were compared at each time point. |
6, 12, and 24 hours and 2, 3, 5, and 7 days after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of participants using analgesics
Time Frame: From the end of treatment to day 7 after treatment
|
Proportion of participants in each group who took rescue analgesic medication (ibuprofen 400 mg, taken only in case of severe pain) during the follow-up period, as self-recorded on the pain record form together with the time and dose of each intake. |
From the end of treatment to day 7 after treatment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B.30.2ATA.0.01.00/559
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.